Navigation Links
Cell Therapeutics, Inc. Reports Outcome of Annual Meeting of Shareholders
Date:10/21/2009

SEATTLE, Oct. 21 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today the results from its Annual Meeting of Shareholders held on Tuesday, October 20, 2009.

At the meeting, shareholders elected Mr. Richard L. Love, Dr. Mary O. Mundinger, and Dr. Jack W. Singer to serve on the Company's Board of Directors until the 2012 Annual Meeting. Shareholders approved the proposals to increase the number of shares available for issuance under its 2007 Equity Incentive Plan, increase the number of shares available for issuance under its 2007 Employee Purchase Plan and issue shares of common stock in lieu of future milestone payments related to the Company's drug candidate brostallicin. Shareholders ratified the selection of Stonefield Josephson, Inc. as the Company's independent auditors for the year ending December 31, 2009.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results. Specifically, the risks and uncertainties include the risk factors listed or described from time to time in the Company's filings with the Securities and Exchange Commission including, without limitation, the Company's most recent filings on Forms 10-K, 10-Q and 8-K. Except as may be required by law, the Company does not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.


    Media Contact:
    Cell Therapeutics, Inc.
    Dan Eramian
    T: 206.272.4343
    C: 206.854.1200
    Lindsey Jesch
    T: 206.272.4347
    F: 206.272.4434
    E: deramian@ctiseattle.com
    www.CellTherapeutics.com/press_room

    Investors Contact:
    Cell Therapeutics, Inc.
    Ed Bell
    T: 206.272.4345
    F: 206.272.4434
    E: '/>"/>
SOURCE  Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
2. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
4. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
7. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
8. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
9. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)...  Flagship Ventures, a leading venture capital and ... today announced the appointment of Stephane ... this role, Mr. Bancel will provide strategic counsel ... addition to working closely with companies in the ... and Chief Executive Officer of Moderna Therapeutics, a ...
(Date:5/22/2013)... , May 22, 2013  Grifols, a global ... , presented results from a study demonstrating that a ... Inhibitor [Human]) increased levels of the alpha 1 ... to levels that are considered within the normal range ... condition in which low levels of the alpha 1 ...
(Date:5/22/2013)... 22, 2013  Ohr Pharmaceutical Inc. (OTCQB: OHRP), a ... for unmet medical needs, today announced the appointment of ... to its Board of Directors. Dr. Almenoff has extensive ... late stage drug development. "We are ... Dr. Irach Taraporewala, CEO of Ohr Pharmaceutical. "She offers ...
Breaking Medicine Technology:Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 2Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 3
... NorthShore University HealthSystem (NorthShore) interventional cardiologist, Ted Feldman , MD, ... sessions from the EVEREST II trial (Endovascular Valve Edge-to-Edge REpair STudy) ... and effective alternative to open heart surgery for select patients with ... ...
... For patients who are living with a heart problem, the option ... condition. From aortic aneurysms to Heart Valve Replacement Surgery , ... definite risks to the patient,s health. However, with a great team ... valve replacement surgery can go into surgery feeling confident. At ...
Cached Medicine Technology:Minimally Invasive Heart Valve Therapy Improves Heart Function, Quality of Life for Mitral Regurgitation Patients 2Minimally Invasive Heart Valve Therapy Improves Heart Function, Quality of Life for Mitral Regurgitation Patients 3Minimally Invasive Heart Valve Therapy Improves Heart Function, Quality of Life for Mitral Regurgitation Patients 4The California Center for Cardiothoracic Surgery Specializes in Heart Valve Replacement Surgery 2The California Center for Cardiothoracic Surgery Specializes in Heart Valve Replacement Surgery 3
(Date:5/22/2013)... be reaping enormous income for patients whose hospital ... in their intensive care units. , In a ... American Journal of Medical Quality , the researchers ... avoidable central line-associated bloodstream infection (CLABSI) costs nearly ... similar infection-free patient. Moreover, hospitals earn nearly nine ...
(Date:5/22/2013)... Recent tragedies including the Oklahoma tornado, ... in Newtown, Connecticut all resulted in serious, and ... medical practitioners train to respond to both adult ... for Children (EMSC) Program specifically provides instruction, education ... patients. It is estimated 30 million children will ...
(Date:5/22/2013)... Space Girl Organics is excited to announce ... I Talk to Strangers Miracle Run/Walk . The 5K ... Park in Cocoa, FL. The event aims to “create miracles” ... movement. , As a sponsor, Space Girl Organics is organizing ... event. Additionally, they are providing bananas for runners and donating ...
(Date:5/22/2013)... Pamela Isom, President and CEO of ... Journal’s 2013 Women of Influence Award in recognition for ... The reception took place on Thursday, May 2 at ... is particularly humbling for the 5,000 people ICE Safety ... is to recognize the four to nine lives saved ...
(Date:5/22/2013)... CA (PRWEB) May 22, 2013 Homeopathic Vibes ... who cannot make it to the store during normal hours. ... , “The change is to accommodate some of our patients ... during the day time or on Saturdays,” says owner and ... are 10 a.m. to 6 p.m. Monday through Friday; weekends ...
Breaking Medicine News(10 mins):Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4Health News:When Tragedies Impact Children – Kentucky Emergency Medical Services for Children (KYEMSC) Offers Specialized Training for Pediatric Emergency Care 2Health News:Space Girl Organics to Sponsor May 25 Miracle Run/Walk 2Health News:Pamela Isom, President and CEO of ICE Safety Solutions Inc. Receives 2013 Women of Influence Recognition and Award 2Health News:Homeopathic Vibes Now Open Late on Wednesdays 2
... According to estimates there are 85,000 Alzheimer patients in ... This spectacular increase is due to the increasing ageing ... process forms the basis of this spectacular rise in ... K.U.Leuven have discovered an important molecular link between Alzheimer,s ...
... to End the Crisis of Poor Self Image ... Challenging Cultural Ideals About Identity and Beauty, ... Eating Disorders,( http://www.remudaranch.com ), the nation,s leading and ... from eating disorders and,FINDINGbalance ( http://www.findingbalance.com ), a ...
... telemedicine is the key to transforming healthcare by making medical care more ... in response to the following problems that plague patients and practitioners in ... inefficient U.S. healthcare system:, * Doctors ... primary care physician, and nearly one-in-four have problems ...
... Switched Patients to Merck,s ... from Decision Resources, WALTHAM, Mass., April 22 ... and advisory firms for pharmaceutical and,healthcare issues, finds ... endocrinologists who consider the cardiovascular safety of,GlaxoSmithKline,s Avandia ...
... VALENCIA, Calif., April 22 On May ... Bittman, MD and internationally,renowned music therapist Christine ... Drumming facilitation training program.,This weekend training includes ... a research-based protocol using group,drumming for health ...
... GeneGo, Inc., the leading,provider of software and databases ... the Chinese University of Hong Kong,Pediatric department will ... drug targets for a large variety of diseases ... to license MetaCore, as well as,species-specific content for ...
Cached Medicine News:Health News:Ground-breaking new insight into the development of Alzheimer's disease 2Health News:Remuda Programs for Eating Disorders and FINDINGbalance Partner to End Poor Self Image 2Health News:Remuda Programs for Eating Disorders and FINDINGbalance Partner to End Poor Self Image 3Health News:Latest Studies Show Consumer-Directed Telemedicine Solutions Like Consult A Doctor Lower Costs While Providing Greater Access to Affordable, Quality Healthcare. 2Health News:Latest Studies Show Consumer-Directed Telemedicine Solutions Like Consult A Doctor Lower Costs While Providing Greater Access to Affordable, Quality Healthcare. 3Health News:Latest Studies Show Consumer-Directed Telemedicine Solutions Like Consult A Doctor Lower Costs While Providing Greater Access to Affordable, Quality Healthcare. 4Health News:Latest Studies Show Consumer-Directed Telemedicine Solutions Like Consult A Doctor Lower Costs While Providing Greater Access to Affordable, Quality Healthcare. 5Health News:Latest Studies Show Consumer-Directed Telemedicine Solutions Like Consult A Doctor Lower Costs While Providing Greater Access to Affordable, Quality Healthcare. 6Health News:Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKline's Avandia Increases Nine-Fold Following Publication of Meta-Analysis 2Health News:Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKline's Avandia Increases Nine-Fold Following Publication of Meta-Analysis 3Health News:Internationally Acclaimed Music and Medicine Program Comes to Chaska 2Health News:GeneGo's First Customer in Hong Kong; The Chinese University of Hong Kong 2
... The new Finnpipette Focus from ... to combine ergonomics with uncompromising ... handle plate offers a custom ... The new shorter tip cones ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Inquire...
... Hamilton is precision, ergonomics, and ... hand fatigue with soft non-slip, contoured ... with smooth, light plunger spring action ... and sterilization without the need for ...
Medicine Products: